Thank you, Mr. Chair.
Good morning. The MS Society would like to thank MP David Yurdiga for sponsoring motion M-192 and this committee for taking the time to study and create recommendations to improve the lives of Canadians living with episodic disabilities.
Let me start with a story.
Imagine this picture: a 29-year-old university graduate, wife and mother to a one-year-old son, starting out her career in the non-profit sector. She walks into the doctor's office one day and walks out not knowing the journey that lies before her. Why? Because she has just been diagnosed with MS. That woman was me 14 years ago.
How would you react when you are told that you have an unpredictable, often disabling disease of the central nervous system, affecting your brain and spinal cord, and they can't say what lies ahead? They tell you that you're one of the 11 diagnosed every day, that it happens to women three times more often than to men, and that Canada has one of the highest rates of MS in the world, with over 77,000 Canadians living with the disease. The problem is that they can't tell you what, when and how severe the symptoms will be, like the ones I've experienced, from fatigue, pain, numbness, spasms, tremors, vertigo and weakness. This is because the symptoms of MS depend on what part of the brain and spinal cord are affected. This can greatly vary from person to person, and from time to time in the same person.
I left that doctor's office, got into my car, called my husband, cried and told him, “Whatever happens, please, I don't want to live in long-term care”. Why was that my reaction? Because that is what I knew of MS at that time. My aunt had passed away when she was in her fifties from a progressive form of MS. She could no longer move on her own or speak except to nod her head. She lived in a long-term care facility with individuals two and three decades older than she was. I was scared that would happen to me. I didn't realize there were others living with this disease and that they didn't have the progressive form that my aunt did. They had what I had been diagnosed with, relapsing-remitting MS.
Relapsing-remitting MS is characterized by unpredictable but clearly defined periods, during which symptoms are apparent. Relapses can last for varying periods, from a few days to several months, and are followed by periods of remission, during which many functions return. Approximately 85% of people diagnosed with MS have this type, also referred to as an episodic disability.
MS impacts all Canadians. It is a disease that affects not only the individuals but also the families who come together to manage the realities of MS. The unpredictable and episodic yet progressive nature of MS makes it a challenge to maintain financial security and to navigate health and community support systems, including access to treatments, care and appropriate housing.
When I was diagnosed, I worried about our family's financial security. My son was just one year old. We were just starting out. We had a mortgage, car payments, student loans and other expenses. What would happen if I had a relapse and I couldn't work full time and needed to work part time while recovering? Were there financial supports that could help me? What I learned then, which is still relevant today, is that the current disability income and employment support programs in Canada were not designed with episodic disability in mind. Many of these programs to support persons with disabilities are built with that binary switch—either you can work or you cannot work—leaving out many people with episodic disabilities who want to work but struggle to continue to work.
This is why the MS Society recommends improving income and employment security by making these supports and programs more flexible and inclusive by including episodic disability in the basic definition of “disability”, changing eligibility criteria and updating policies and legislation across programs, such as employment insurance sickness benefits, Canada pension plan disability, and the disability tax credit.
Being able to stay employed means I've had access to MS disease-modifying treatments approved by Health Canada to reduce relapses and disability progression. Because I've been able to access these medications and other extended health benefits, I've been able to stay working. It becomes a catch-22. Staying healthier for longer periods and reducing the severity of periods of illness when they do occur are key factors in job retention for people with episodic disabilities. Access to affordable medications and health benefits is imperative. Access to treatments and health care is key for people living with episodic disabilities.
This disease, MS, creates a life of uncertainty and unpredictability, but what should and can be certain and predictable are the supports people with MS and episodic disabilities have. I commend this committee for studying this motion, thus increasing awareness of episodic disability in Canada. By viewing policy and legislation through an episodic-disability lens and recommending important changes, we will achieve better equity in the supports for Canadians living with episodic disabilities.
Thank you very much for this opportunity to speak.